Mi Kyung Kim

Dr. Mi Kyung Kim


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HJHaejin Joo
Haejin Joo
JPJonghyun Park
Jonghyun Park
CSChanutchamon Sutthiwanjampa
Chanutchamon Sutthiwanjampa
HKHan Koo Kim
Han Koo Kim
TBTaehui Bae
Taehui Bae
HPHansoo Park
Hansoo Park
Polydimethylsiloxane (PDMS) is a biocompatible polymer that has been applied in many fields. However, the surface hydrophobicity of PDMS can limit successful implementation, and this must be reduced by surface modification to improve biocompatibility. In this study, we modified the PDMS surface with a hydrogel and investigated the effect of this on hydrophilicity, bacterial adhesion, cell viability, immune response, and biocompatibility of PDMS. Hydrogels were created from hyaluronic acid and gelatin using a Schiff-base reaction. The PDMS surface and hydrogel were characterized using nuclear magnetic resonance, X-ray photoelectron spectroscopy, attenuated total reflection Fourier-transform infrared spectroscopy, and scanning electron microscopy. The hydrophilicity of the surface was confirmed via a decrease in the water contact angle. Bacterial anti-adhesion was demonstrated for Pseudomonas aeruginosa, Ralstonia pickettii, and Staphylococcus epidermidis, and viability and improved distribution of human-derived adipose stem cells were also confirmed. Decreased capsular tissue responses were observed in vivo with looser collagen distribution and reduced cytokine expression on the hydrogel-coated surface. Hydrogel coating on treated PDMS is a promising method to improve the surface hydrophilicity and biocompatibility for surface modification of biomedical applications.

7 April 2020 in Journal of Educational Evaluation for Health Professions
Verified
Journal Article
Open access
PDF file
HYHyo Hyun Yoo
Hyo Hyun Yoo
MKMi Kyung Kim
Mi Kyung Kim
YYYoo Sang Yoon
Yoo Sang Yoon
KLKeunmi Lee
Keunmi Lee
JLJong Hun Lee
Jong Hun Lee
WPWon Kyun Park
Won Kyun Park
This review presents information on changes in the accreditation standards of medical schools in Korea by the Korean Institute of Medical Education and Evaluation (KIMEE) from 2000 to 2019. Specifically, the following aspects are explained: the development process, setting principles and directions, evaluation items, characteristics of the standards, and validity testing over the course of 4 cycles. The first cycle of accreditation (2000–2005) focused on ensuring the minimum requirements for the educational environment. The evaluation criteria emphasized the core elements of medical education, including facilities and human resources. The second cycle of accreditation (2007–2010) emphasized universities’ commitment to social accountability and the pursuit of excellence in medical education. It raised the importance of qualitative standards for judging the content and quality of education. In the post-second accreditation cycle (2012–2018) which means third accreditation cycle, accreditation criteria were developed to standardize the educational environment and programs and to be used for curriculum development in order to continually improve the quality of basic medical education. Most recently, the ASK 2019 (Accreditation Standards of KIMEE 2019) accreditation cycle focused on qualitative evaluations in accordance with the World Federation of Medical Education’s accreditation criteria to reach the international level of basic medical education, which emphasizes the need for a student-centered curriculum, communication with society, and evaluation through a comprehensive basic medical education course. The KIMEE has developed a basic medical education evaluation and accreditation system in a step-by-step manner, as outlined above. Understanding previous processes will be helpful for the future development of accreditation criteria for medical schools in Korea.

12 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QNQue Thanh Thanh Nguyen
Que Thanh Thanh Nguyen
HRHyemin Rhee
Hyemin Rhee
MKMi Kyung Kim
Mi Kyung Kim
MLMoo Yeol Lee
Moo Yeol Lee
ELEun-Ju Lee
Eun-Ju Lee
Intra‐abdominal adhesion is a complication following abdominal surgery caused by the suppression of fibrinolytic activity and aggravated fibroblast invasion of the injured area, which may lead to chronic illnesses such as chronic pain, intestinal obstruction, and female infertility. This study hypothesized that lumbrokinase, a fibrinolytic enzyme extracted from the earthworm, supports the wound healing process. Therefore, we assessed the effect of lumbrokinase on intra‐abdominal adhesion. Lumbrokinase treatment significantly decreased the severity and the area of intra‐abdominal adhesion in vivo in a dose‐dependent manner compared with the controls (untreated and hyaluronate‐treated). Lumbrokinase‐associated adverse effects were not observed. Immunohistochemical analysis of adhesion tissues revealed a loosened adhesive band between tissues, coupled with significantly decreased peritoneal thickening in the lumbrokinase‐treated group versus the control group. Three‐dimensional spheroid, MTT, and scratch wound migration assays using the IMR‐90 human fibroblast cell line demonstrated that lumbrokinase significantly attenuated the migration and adhesive activity of fibroblasts without compromising cell proliferation. The luciferase assay and western blot analysis showed that lumbrokinase inhibited the AP‐1/ICAM‐1 cell adhesion signaling pathway. Therefore, lumbrokinase decreases intra‐abdominal adhesion and peritoneal thickening by augmenting fibrinolytic action and inhibiting fibroblast migration and adhesive activity via attenuation of the AP‐1/ICAM‐1 signaling pathway. Lumbrokinase is thus a promising agent to prevent intra‐abdominal adhesion.

29 October 2021 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
ISIlchan Song
Ilchan Song
Young Koung LeeYoung Koung Lee
Young Koung Lee
JKJinwook Kim
Jinwook Kim
SLSeung-Won Lee
Seung-Won Lee
SPSe Ra Park
Se Ra Park
KKKisung Ko
Kisung Ko
Ilchan Song, Young Koung Lee, Jin Wook Kim, Seung-Won Lee, Se Ra Park, Hae Kyung Lee, Soyeon Oh, Kinarm Ko, Mi Kyung Kim, Soon Ju Park, Dae Heon Kim, Moon-Soo Kim, Do Sun Kim, and Kisung Ko. Mol. Cells 2021;44:770-9. https://doi.org/10.14348/molcells.2021.2002

14 September 2020 in Cancer Investigation
Verified
Journal Article
Closed access
JKJi-Hye Kim
Ji-Hye Kim
MCMin-Jae Cha
Min-Jae Cha
MKMi Kyung Kim
Mi Kyung Kim
YCYun Jae Chung
Yun Jae Chung
ELEun-Ju Lee
Eun-Ju Lee
Primary pulmonary choriocarcinoma (PPC) is frequently fatal due to difficulties in diagnosis. Few cases of PPC are bilateral and involve exceptionally large nodules. Here, we report an unusual case of PPC involving disseminated bilateral nodules, which was misdiagnosed as tuberculosis, but successfully treated using chemotherapy. A review of 65 cases revealed six cases of bilateral disease, including the present one. Patients treated with surgery, chemotherapy, or a combination of both showed similar treatment outcomes; however, chemotherapy may be the preferred option. Despite its rarity, PPC should be included in the differential diagnosis for all lung nodules to enable early detection.

1 April 2008
Verified
Journal Article
Closed access
SLSeung Hyun Lee
Seung Hyun Lee
HKHyung Joon Kim
Hyung Joon Kim
JMJang Sik Mun
Jang Sik Mun
HOHyoung-Chul Oh
Hyoung-Chul Oh
HLHyun Woong Lee
Hyun Woong Lee
MKMi Kyung Kim
Mi Kyung Kim